Metformin inhibits the proliferation of benign prostatic epithelial cells

Keyphrases

• Metformin 100%
• Prostate Epithelial Cells 100%
• Benign Prostatic 100%
• Benign Prostatic Hyperplasia 80%
• Growth Factors 70%
• Insulin-like 70%
• Insulin-like Growth Factor 1 Receptor (IGF1R) 40%
• Cell Proliferation 20%
• Cell Population 20%
• Epithelial Cells 20%
• Fibroblasts 20%
• Conditioned Medium 20%
• M Cells 20%
• 3T3 Cells 20%
• Diabetes 10%
• Prostate 10%
• Epithelial Cell Proliferation 10%
• Immunocytochemistry 10%
• Flow Cytometry 10%
• Epidemiologic Studies 10%
• Stromal Cells 10%
• Culture Media 10%
• Paracrine Mechanism 10%
• Western Blot 10%
• Type 2 Diabetes Prevention 10%
• MTS Assay 10%
• 1 Receptor 10%
• Dose-dependent 10%
• Antidiabetic Drug 10%
• Elderly Men 10%

Medicine and Dentistry

• Epithelial Cell 100%
• Glycon 100%
• Prostate Hypertrophy 80%
• Somatomedin C 60%
• Receptor 40%
• Secretion (Process) 30%
• Cell Proliferation 30%
• Cell Population 20%
• Cell Cycle 20%
• 3T3 Cells 20%
• Microfold Cell 20%
• Fibroblast 20%
• Stromal Cell 10%
• Diabetes 10%
• Maturity Onset Diabetes of the Young 10%
• Flow Cytometry 10%
• Enzyme Linked Immunosorbent Assay 10%
• Cohort Effect 10%
• Cell Line 10%
• Western Blot 10%
• Immunocytochemistry 10%
• Somatomedin C Receptor 10%
• MTS Assay 10%
• Anti-Diabetic Medication 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Metformin 100%
• Prostate Hypertrophy 80%
• Somatomedin C 60%
• Receptor 40%
• Western Blot 10%
• Flow Cytometry 10%
• Enzyme-Linked Immunosorbent Assay 10%
• Somatomedin C Receptor 10%
• Anti-Diabetic Medication 10%
• Maturity Onset Diabetes of the Young 10%